Cha Albert's Form 4 filing
Frazier Life Sciences Acquisition Corp. IIFLSC · filed Oct 15, 2026
- Accession no.
- 0001193125-26-422957
- Filed
- Oct 15, 2026, 4:40 PM ET
- Trade date
- Oct 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $3.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cha AlbertCIK 0001397906 | Director, Officer (Chief Executive Officer), 10% Owner |
| Frazier Life Sciences Public Fund, L.P.CIK 0001863769 | 10% Owner |
| FHMLSP, L.L.C.CIK 0001879465 | 10% Owner |
| FHMLSP, L.P.CIK 0001879466 | 10% Owner |
| Frazier Life Sciences Holdings II LLCCIK 0002153600 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Class A ordinary shares | PPurchaseAcquired | +300,000 | $10.00 | +$3,000,000 | 300,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.